Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Urology : Official Journal of the Japanese Urological Association|January 6, 2009
Bladder cancer biomarkers and their role in surveillance and screeningAngela A G Van Tilborg, Chris H Bangma, Ellen C Zwarthoff
Urologic Oncology|February 4, 2010
Bladder cancer: novel molecular characteristics, diagnostic, and therapeutic implicationsLucie C Kompier, Angela A G van Tilborg, Ellen C Zwarthoff
The Journal of Pathology|October 11, 2002
The random development of LOH on chromosome 9q in superficial bladder cancersAngela A G van Tilborg, Annie de Vries, Maarten de Bont, et al.
Plos One|January 26, 2010
Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genesIrene Lurkin, Robert Stoehr, Carolyn D Hurst, et al.
European Urology|January 31, 2012
Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markersRaju Kandimalla, Angela A G van Tilborg, Lucie C Kompier, et al.
Gynecologic Oncology|August 27, 2014
Sulfated sugars in the extracellular matrix orchestrate ovarian cancer development: 'when sweet turns sour'Myrtille J E Vallen, Sophieke C H A van der Steen, Angela A G van Tilborg, et al.
The Journal of Pathology|December 15, 2005
Lack of genetic and epigenetic changes in meningiomas without NF2 lossAngela A G van Tilborg, Bruno Morolli, Micheline Giphart-Gassler, et al.
Biomarkers in Medicine|August 16, 2014
Novel single-chain antibody GD3A10 defines a chondroitin sulfate biomarker for ovarian cancerMyrtille J E Vallen, Angela A G van Tilborg, Maria H Tesselaar, et al.
Gynecologic Oncology|January 6, 2016
Prognostic significance of highly sulfated chondroitin sulfates in ovarian cancer defined by the single chain antibody GD3A11Sophieke C H A van der Steen, Angela A G van Tilborg, Myrtille J E Vallen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2013
A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urineRaju Kandimalla, Roy Masius, Willemien Beukers, et al.
Pageof 2